or otherwise influence opiate receptors, including opioid
agonist.
§ 5102. Safe opioid prescription education.
(a) Requirement.--Beginning January 1, 2018, each licensing
board shall require that an applicant submit proof to the
appropriate board that the applicant has completed approved
education on the specific topic of safe prescription of a
controlled substance containing an opioid prior to the granting
of a license or certificate that would allow the applicant to
prescribe a controlled substance containing an opioid.
(b) Curriculum. --Beginning August 1, 2017, the licensing
boards shall, by joint regulation, implement a safe prescription
of a controlled substance containing an opioid curriculum. The
curriculum may be offered in colleges or by providers approved
by the licensing boards and shall include all of the following:
(1) Current, age-appropriate information relating to
pain management.
(2) Multimodal treatments for chronic pain that minimize
the use of a controlled substance containing an opioid.
(3) If a controlled substance containing an opioid is
indicated, instruction on safe methods of prescribing a
controlled substance containing an opioid that follow
guideline-based care.
(4) Identification of patients who have risk factors for
developing problems with prescription of a controlled
substance containing an opioid.
(5) Training on managing substance abuse disorders as a
chronic disease.
(c) Separation from standardized curriculum.--The education
required under this chapter shall not be considered part of the
20160SB1368PN2075 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30